Compass Wealth Management LLC Amneal Pharmaceuticals, Inc. Transaction History
Compass Wealth Management LLC
- $425 Billion
- Q3 2024
A detailed history of Compass Wealth Management LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Compass Wealth Management LLC holds 200 shares of AMRX stock, worth $1,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$1,564
Previous $1.27 Million
31.02%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
184Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$170 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$114 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$96.4 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$88.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$83.8 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.18B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...